OTCPK:AKMN.F

Stock Analysis Report

Executive Summary

Akumin Inc. provides outpatient diagnostic imaging services in the United States.

Snowflake

Fundamentals

Fair value with concerning outlook.


Similar Companies

Share Price & News

How has Akumin's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AKMN.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-0.3%

AKMN.F

5.3%

US Healthcare

0.5%

US Market


1 Year Return

3.9%

AKMN.F

4.4%

US Healthcare

16.1%

US Market

Return vs Industry: AKMN.F matched the US Healthcare industry which returned 4.4% over the past year.

Return vs Market: AKMN.F underperformed the US Market which returned 16.1% over the past year.


Shareholder returns

AKMN.FIndustryMarket
7 Day-0.3%5.3%0.5%
30 Day9.7%12.3%3.9%
90 Day4.1%15.7%6.6%
1 Year3.9%3.9%6.2%4.4%18.7%16.1%
3 Yearn/a51.9%45.1%47.2%37.7%
5 Yearn/a69.6%58.0%61.5%43.7%

Price Volatility Vs. Market

How volatile is Akumin's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Akumin undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: AKMN.F ($3.24) is trading below our estimate of fair value ($7.19)

Significantly Below Fair Value: AKMN.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: AKMN.F is poor value based on its PE Ratio (40x) compared to the Healthcare industry average (21.5x).

PE vs Market: AKMN.F is poor value based on its PE Ratio (40x) compared to the US market (18x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AKMN.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AKMN.F is good value based on its PB Ratio (1.7x) compared to the US Healthcare industry average (2.6x).


Next Steps

Future Growth

How is Akumin forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

16.2%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AKMN.F's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if AKMN.F's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AKMN.F's revenue (16.2% per year) is forecast to grow faster than the US market (7.3% per year).

High Growth Revenue: AKMN.F's revenue (16.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AKMN.F's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Akumin performed over the past 5 years?

54.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AKMN.F has large one-off items impacting its financial results.

Growing Profit Margin: AKMN.F's current net profit margins (2.5%) are lower than last year (3.7%).


Past Earnings Growth Analysis

Earnings Trend: AKMN.F has become profitable over the past 5 years, growing earnings by 54.5% per year.

Accelerating Growth: AKMN.F's earnings growth over the past year (0.6%) is below its 5-year average (54.5% per year).

Earnings vs Industry: AKMN.F earnings growth over the past year (0.6%) underperformed the Healthcare industry 9.7%.


Return on Equity

High ROE: AKMN.F's Return on Equity (5.4%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Akumin's financial position?


Financial Position Analysis

Short Term Liabilities: AKMN.F's short term assets ($95.9M) exceeds its short term liabilities ($38.1M)

Long Term Liabilities: AKMN.F's short term assets ($95.9M) do not cover its long term liabilities (461.0M)


Debt to Equity History and Analysis

Debt Level: AKMN.F's debt to equity ratio (233.3%) is considered high.

Reducing Debt: Insufficient data to determine if AKMN.F's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: AKMN.F's debt is not well covered by operating cash flow (4.5%).

Interest Coverage: AKMN.F's interest payments on its debt are not well covered by EBIT (1.6x coverage).


Balance Sheet

Inventory Level: AKMN.F has a high level of physical assets or inventory.

Debt Coverage by Assets: AKMN.F's debt is not covered by short term assets (assets are 0.3x debt).


Next Steps

Dividend

What is Akumin's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.5%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate AKMN.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate AKMN.F's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AKMN.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AKMN.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AKMN.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Akumin's salary, the management and board of directors tenure and is there insider trading?

4.2yrs

Average management tenure


CEO

Riadh Zine Zine-El-Abidine (47yo)

0yrs

Tenure

US$2,444,013

Compensation

Mr. Riadh Zine-El-Abidine also known as Riadh Zine, serves as Chief Executive Officer and President at Akumin Inc. Mr. Zine serves as President and Chief Executive Officer of Elite Imaging Inc. Mr. Zine is ...


CEO Compensation Analysis

Compensation vs Market: Riadh Zine's total compensation ($USD2.44M) is above average for companies of similar size in the US market ($USD1.13M).

Compensation vs Earnings: Riadh Zine's compensation has been consistent with company performance over the past year.


Management Age and Tenure

4.2yrs

Average Tenure

Experienced Management: AKMN.F's management team is considered experienced (4.2 years average tenure).


Board Age and Tenure

2.7yrs

Average Tenure

59yo

Average Age

Experienced Board: AKMN.F's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: AKMN.F insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$79,31501 Oct 19
Riadh Zine-El-Abidine
EntityIndividual
Role
Chief Executive Officer
President
Shares30,000
Max PriceUS$2.64
BuyUS$1,050,00001 Oct 19
James Webb
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares300,000
Max PriceUS$3.50
SellUS$83528 Jun 19
Amy Adams
EntityIndividual
Role
Senior Key Executive
Senior Vice President
Shares300
Max PriceUS$2.80
SellUS$9,30021 Jun 19
Michael Meredith
EntityIndividual
Shares3,367
Max PriceUS$2.76
SellUS$14,11614 Jun 19
Amy Adams
EntityIndividual
Role
Senior Key Executive
Senior Vice President
Shares5,000
Max PriceUS$2.82
SellUS$18,23914 Jun 19
Michael Luckey
EntityIndividual
Shares6,635
Max PriceUS$2.77
SellUS$124,03103 Jun 19
Amy Adams
EntityIndividual
Role
Senior Key Executive
Senior Vice President
Shares50,000
Max PriceUS$2.48
SellUS$17,04203 Jun 19
Marcus Quesenberry
EntityIndividual
Shares6,735
Max PriceUS$2.53

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.6%.


Management Team

  • Amy Adams

    Senior Vice President

    • Tenure: 0yrs
    • Compensation: US$795.01k
  • Riadh Zine Zine-El-Abidine (47yo)

    President

    • Tenure: 0yrs
    • Compensation: US$2.44m
  • Rohit Navani

    Executive VP & COO

    • Tenure: 5.1yrs
    • Compensation: US$1.15m
  • Mohammad Saleem

    CFO & Corporate Secretary

    • Tenure: 4.2yrs
    • Compensation: US$704.66k
  • Laura Kassa

    Senior Vice President

    • Tenure: 2.8yrs
    • Compensation: US$989.12k
  • Darren Speed

    Chief Compliance Officer

    • Tenure: 0yrs
  • Adam Fabian

    Corporate Controller

    • Tenure: 0yrs
  • Matt Cameron

    Senior VP & General Counsel

    • Tenure: 0yrs
  • Karen Moore

    Vice President of Human Resources

    • Tenure: 0yrs
  • Christopher Fitzgerald

    Chief Revenue Officer of Akumin Corp

    • Tenure: 0yrs

Board Members

  • Stan Dunford (69yo)

    Chairman

    • Tenure: 0yrs
    • Compensation: US$169.04k
  • James Webb (59yo)

    Independent Director

    • Tenure: 2.3yrs
    • Compensation: US$177.82k
  • Riadh Zine Zine-El-Abidine (47yo)

    President

    • Tenure: 0yrs
    • Compensation: US$2.44m
  • Tom Davies (60yo)

    Independent Director

    • Tenure: 2.7yrs
    • Compensation: US$185.32k
  • Murray Lee (59yo)

    Lead Director

    • Tenure: 0yrs
    • Compensation: US$195.32k

Company Information

Akumin Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Akumin Inc.
  • Ticker: AKMN.F
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$308.119m
  • Listing Market Cap: CA$231.495m
  • Shares outstanding: 69.24m
  • Website: https://www.akumin.com

Number of Employees


Location

  • Akumin Inc.
  • 151 Bloor Street West
  • Suite 603
  • Toronto
  • Ontario
  • M5S 1S4
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AKUTSX (The Toronto Stock Exchange)YesCommon SharesCACADDec 2017
AKMN.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDDec 2017

Biography

Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2018, the company operated 95 imaging centers located in Florida, Pennsylvania, Delaware, Texas, Illinoi ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/21 01:07
End of Day Share Price2019/11/19 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.